by Sasha Nimmo Senior staff from Australia’s National Disability Insurance Agency (NDIA) met with Emerge Australia and ME Australia to
Melbourne based scientists have just published a study finding activin B is a biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (MECFS) using the Canadian Consensus Criteria.
by Sasha Nimmo Queensland’s Griffith University is home to the National Centre for Neuroimmunology and Emerging Diseases (NCNED), one of
by Sasha Nimmo Between 24,000 – 60,000 Australians have severe ME. This is the first in a series telling the
by Sasha Nimmo Around 38% of Australians diagnosed with chronic fatigue syndrome (CFS) and Myalgic Encephalomyelitis (ME) do not meet
March 2015 has been a busy month for biomarker discoveries for patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: two new papers published and one patent registered.
Australia needs to leave behind ME/CFS and CFS/ME. Why is it important to use ME and CFS?
by Sasha Nimmo A recent paper begins “there has been considerable controversy regarding how to name and define the illnesses
by Sasha Nimmo Australian scientists announce they have made a breakthrough in chronic fatigue syndrome testing, now looking for partners
© 2021 ME Australia. All Rights Reserved.